Aura Biosciences Inc AURA 深 滬
已收盤 05-22 16:00:00 美东时间
7.60
-0.050
-0.65%
華盛通- 最 高7.879
- 今 開7.66
- 成交量 27.82万股
- 最 低 7.585
- 昨 收 7.65
- 總市值 7.86亿
- 52周最高 9.535
- 市盈率 靜 --
- 換手率 0.27%
- 52周最低 4.73
- 委 比 20.63%
- 總股本 1.03亿
- 歷史最高 26.16
- 量 比 0.40
- 振 幅 3.84%
- 歷史最低 4.345
- 每 手 1
- 風險率 0.68%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多U.S. RESEARCH ROUNDUP-Aecom, Humana, Mosaic
U.S. RESEARCH ROUNDUP-Aecom, Humana, Mosaic May 13 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Aecom, Humana and Mosaic on Wednesday. HIGHLIGHTS * Aecom ACM.N : RBC cuts target price to $111 from $142 * Humana HUM.N
05-13 15:31
Aura Biosciences Q1 EPS $(0.50) Misses $(0.39) Estimate
Aura Biosciences (NASDAQ:AURA) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $(0.39) by 28.21 percent. This is a 9.09 percent increase over losses of $(0.55) per share from
05-12 05:30
Aura Biosciences reports Q1 results, appoints new CEO
Aura Biosciences Inc ( ($AURA) ) has shared an update. On May 11, 2026, Aura Bi...
05-12 05:04
美股牛股 | 多重利好！Circle大涨近20%，CLARITY法案取得关键进展并获但斌买入；GBTG飙升超57%
多重利好！Circle大涨近20%，CLARITY法案取得关键进展并获但斌买入；GBTG飙升超57%，获Long Lake以63亿美元收购>>
05-05 18:24
Aura Biosciences Announces Stock Repurchase Agreement with Shareholder
Aura Biosciences Inc ( ($AURA) ) just unveiled an update. On April 30, 2026, Au...
05-05 05:39
Aura Biosciences Prices ~$260.3M Offering Of Common Shares, Pre-Funded Warrants
Aura Biosciences, Inc. ("Aura") (NASDAQ:AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today announced the pricing of an underwritten
05-04 21:09
Aura Biosciences Advances CoMpass Phase 3 Trial Progress
Aura Biosciences Inc ( ($AURA) ) has shared an update. On April 30, 2026, Aura ...
05-04 18:48
Aura Plans Share Sale With Option for Additional Stock Purchase
Aura Biosciences, Inc. ("Aura") (NASDAQ:AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today announced the launch of an underwritten
05-04 18:11
美股大行评级 | 瑞银：维持Visa"买入"评级！目标价从390美元升至410美元
今日重点评级关注：HC Wainwright & Co.：维持Protara Therapeutics"买入"评级，目标价从23美元升至27美元；BTIG：维持Black Diamond Therapeutic"买入"评级，目标价从10美元升至11美元
04-30 19:24
HC Wainwright & Co. Maintains Buy on Aura Biosciences, Raises Price Target to $24
HC Wainwright & Co. analyst Andrew S. Fein maintains Aura Biosciences (NASDAQ:AURA) with a Buy and raises the price target from $22 to $24.
04-29 19:42
